23 August 2024
Federal Service for Surveillance in Healthcare (Roszdravnadzor) has issued a registration certificate for a medical device featuring artificial intelligence, which has been developed by the Ryzhikh National Medical Research Center of Proctology, in collaboration with Alnisoft and the Ministry of Health of the Russian Federation.
The new AI assistant, named ArtInCol, has been designed for detecting colon tumors during colonoscopy. This computer vision-based system assists doctors in real time by highlighting subtle polyps and adenoids, greatly enhancing diagnostic accuracy and enabling timely cancer prevention.
“Work on creating the ArtInCol medical decision support system began in 2022 on the initiative and with the support of the Ministry of Health of the Russian Federation. The registered solution allows us to broadcast the experience of the center’s leading specialists in detecting colon tumors. This year, we conducted a prospective clinical trial on 100 patients, which demonstrated an impressive increase in the detection rate of colon tumors from 40.6 to 56.4% when using ArtInCol.
In addition, under the leadership of the center, a randomized multicenter clinical trial has been initiated, designed for 1000 patients, in which Moscow City Clinical Hospital No. 31, the endoscopy center of the Botkin MMNC of the Health Department of the City of Moscow, as well as the Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Bashkortostan are participating,” said Professor Sergei Achkasov, Director of the A. N. Ryzhikh National Medical Research Center of Proctology of the Ministry of Health of the Russian Federation.
PrintOctober 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
DSM Group predicts the Russian pharmaceutical market will grow by 10% annually
18 October 2024
An extra 6.1 billion rubles will be allocated for drug provision in 2025
18 October 2024
Pharmasyntez to build heparin production plant in Tatarstan
17 October 2024
17 October 2024